Show
Sort by
-
Risk adjusted benchmarking of clinical anastomotic leakage rate after total mesorectal excision in the context of an improvement project
-
- Journal Article
- A1
- open access
Quality of care indicators in rectal cancer
-
Double blind randomized phase II study with radiation+5-fluorouracil +/- celecoxib for resectable rectal cancer
-
Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer
-
Adjuvant chemoradiation alone versus chemoradiation after curative resection for pancreatic cancer: feasibility results of a randomised EORTC/FFCD/GERCOR study (40013/22012/0304)
-
Adjuvant chemoradiation after curative resection for pancreatic cancer is feasible: results of a randomised EORTC/FFCD/GERCOR study
-
Adjuvant chemotherapy alone versus chemoradiation after curative resection for pancreatic cancer: feasibility results of a randomised EORTC/FFCD/GERCOR phase I/II study (40013/22012/0304)
-
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
-
Definition and delineation of the clinical target volume for rectal cancer
-
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)